Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently... see more

OTCPK:ARLZQ - Post Discussion

Old API Wind-down Ltd - Ordinary Shares > Is this a problem? Didn't expect this...but did some dd and.
View:
Post by MagaTrump on May 08, 2018 8:34pm

Is this a problem? Didn't expect this...but did some dd and.

I thought the 70% drop in SP (share price) was unjustified since I believed it wasn't a true reflection of their sales in the US..BUT after some very easy due dilligence I see that this is apparently NOT the case, the US was most of their revenue, see the screen shot of their presentation. Here's what we need to consider, since the compnay hasn't made any money after liabilities are added in, maybe the US actually WAS their greatest liability, in terms of trade deals, tarrifs, etc...so maybe this was just basically tearing off a badaid very quickly, and then eventually the market will reflect their true potential value? Who knows...any ideas about this company's future????  Cheers! [img]https://Screen_Shot_2018_05_08_at_8_23_31_PM[/img]
Comment by GoldenDilemma on May 09, 2018 10:38am
Company has a shelf filed. They will reverse split, sell those registered shares to generate capital. Management will remain on salary. Longs will be diluted - new longs will be lead to the slaughter. Shorts will hit the reverse split price and down it will go. Toxic financing. Avoid ARLZ - ffs!!!!!!!!!!!!!!!
Comment by GoldenDilemma on May 09, 2018 10:42am
And, why has this been so hard for longs to understand? Yosprala was a failure. Zontivity is a failure. The company is an absolute failure. Management got rich at your expense. Longs missed the forest for the trees and have paid the price. Take it as a learning experience and LEARN how to properly read these situations instead of hoping (or holding and hoping) for the best case scenario).
Comment by Floridas2000 on May 09, 2018 12:21pm
Yes this was a failure.  I made a profit from Tribute and the money I lost with Aralez was inconsequential so I am neutral.  I was hoping for big things from Adams but Yosprala was supposed to be the saviour and when it failed there was no reason for the merger.  Any other purchases after that were either trying to succeed where others failed or a long shot. Adams was a huge ...more  
Comment by PoorOpinion on May 09, 2018 2:30pm
The US was a failure, certain to kill the company. They've amputated it which is a good thing but what is left is a tiny fraction of what was there before. The market cap has significantly adjusted to reflect that. For those holding before its a nightmare, for those thinking of jumping in you have to make your own decision on whether you think the reaction was overdone. Most of the expected ...more  
Comment by PoorOpinion on May 09, 2018 2:33pm
lol Freudian slip, that should have read trusted with 100's of millions of $$$$, maybe they should have only been trusted with 100's of dollars instead :)